FrancophonIA/ELRC3.0 huggingface dataset:
English: Cinacalcet Mylan 90 mg film-coated tablets cinacalcet
Slovenian: Cinakalcet Mylan 90 mg filmsko obložene tablete cinakalcet
English: Protein binding of cinacalcet is not affected by impaired hepatic function.
Slovenian: Okvarjeno delovanje jeter ne vpliva na vezavo cinakalceta na beljakovine.
English: Cinacalcet Mylan 60 mg film-coated tablets cinacalcet
Slovenian: Cinakalcet Mylan 60 mg filmsko obložene tablete cinakalcet
English: Musculoskeletal and connective tissue disorders
Slovenian: Bolezni mišičnoskeletnega sistema in vezivnega tkiva mialgija spazmi mišic bolečine v hrbtu
English: Puh/Tel: + 358 20 720 9555
Slovenian: Suomi/Finland Mylan Finland OY Puh/Tel: + 358 20 720 9555 (Sverige/Ruotsi)
English: • abdominal pain, abdominal pain - upper
Slovenian: • bolečine v trebuhu, bolečine v zgornjem delu trebuha,
English: The other ingredients are cellulose, microcrystalline; silica, colloidal anhydrous; povidone; crospovidone; magnesium stearate.
Slovenian: Pomožne snovi so: mikrokristalna celuloza, brezvodni koloidni silicijev dioksid.
English: The primary endpoint of the study was a reduction of serum calcium of ≥ 1 mg/dl (≥ 0.25 mmol/l).
Slovenian: Cinakalcet so dobivali v odmerkih od 30 mg dvakrat na dan do 90 mg štirikrat na dan. Primarni cilj študije je bilo znižanje kalcija v serumu za ≥ 1,0 mg/dl (≥ 0,25 mmol/l).
English: Significant reductions in iPTH, serum calcium-phosphorus product (Ca x P), calcium, and phosphorus were observed in the cinacalcet treated patients compared with placebo-treated patients receiving standard care, and the results were consistent across the 3 studies.
Slovenian: Pri prejemnikih cinakalceta so v primerjavi z bolniki, ki so prejemali placebo in standardno oskrbo, ugotovili značilno znižanje iPTH, zmnožka kalcija in fosforja v serumu (Ca x P) ter kalcija in fosforja.
English: Talk to your doctor, pharmacist or nurse before taking Cinacalcet Mylan.
Slovenian: Pred začetkom jemanja zdravila Cinakalcet Mylan se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: Seizures† Dizziness Paraesthesia Headache
Slovenian: Bolezni prebavil navzea bruhanje dispepsija driska bolečine v trebuhu bolečine v zgornjem delu trebuha zaprtost
English: HDPE bottle with polypropylene (PP) screw cap closure with induction sealing liner containing 100 tablets.
Slovenian: Zdravilo Cinakalcet Mylan 30 mg, filmsko obložene tablete HDPE plastični vsebnik s polopropilensko (PP) navojno zaporko z indukcijskim pečatom s 100 tabletami.
English: 12.5 mm x 8.0 mm, green, film-coated, oval, biconvex, bevelled edge tablet debossed with M on one side of the tablet and CI60 on the other side.
Slovenian: Zdravilo Cinakalcet Mylan 60 mg filmsko obložene tablete Zelena, ovalna, bikonveksna filmsko obložena tableta z zglajenim robom, dimenzij 12,5 mm x 8,0 mm z vtisnjeno oznako "M" na eni strani in "CI60" na drugi strani.
English: If you forget to take Cinacalcet Mylan Do not take a double dose to make up for a forgotten dose.
Slovenian: Ne vzemite dvojnega odmerka, da bi nadomestili izpuščeni odmerek.
English: • dizziness
Slovenian: • izpuščaj,
English: 14.3 mm x 9.0 mm, green, film-coated, oval, biconvex, bevelled edge tablet debossed with M on one side of the tablet and CI90 on the other side.
Slovenian: Zdravilo Cinakalcet Mylan 90 mg filmsko obložene tablete Zelena, ovalna, bikonveksna filmsko obložena tableta z zglajenim robom, dimenzij 14,3 mm x 9,0 mm z vtisnjeno oznako "M" na eni strani in "CI90" na drugi strani.
English: 10.0 mm x 6.4 mm, green, film-coated, oval, biconvex, bevelled edge tablet debossed with M on one side of the tablet and CI30 on the other side.
Slovenian: Zdravilo Cinakalcet Mylan 30 mg filmsko obložene tablete Zelena, ovalna, bikonveksna filmsko obložena tableta z zglajenim robom, dimenzij 10,0 mm x 6,4 mm z vtisnjeno oznako "M" na eni strani in "CI30" na drugi strani.
English: Due to the potential for 2 to 4 fold higher plasma levels of cinacalcet in patients with moderate to severe hepatic impairment (Child-Pugh classification), cinacalcet should be used with caution in these patients and treatment should be closely monitored (see sections 4.2 and 5.2).
Slovenian: Pri bolnikih z zmerno do hudo okvaro jeter (razvrstitev po Child-Pughu) obstaja možnost za 2- do 4kratno zvišanje koncentracije cinakalceta v plazmi.
English: • medicines used to treat depression (amitriptyline, desipramine, nortriptyline and clomipramine)
Slovenian: Zdravilo Cinakalcet Mylan lahko vpliva na delovanje zdravil, kot so naslednja: • zdravila za zdravljenje depresije (amitriptilin, dezipramin, nortriptilin in klomipramin),
English: The recommended dose is two inhalations twice a day.
Slovenian: Priporočeni odmerek sta dve inhalaciji dvakrat na dan.
English: This medicine is the same as Trimbow, which is already authorised in the EU.
Slovenian: To zdravilo je enako zdravilu Trimbow, ki je že odobreno v EU.
English: Riarify received a marketing authorisation valid throughout the EU on 23 April 2018.
Slovenian: Za zdravilo Riarify je bilo 23. aprila 2018 izdano dovoljenje za promet, veljavno po vsej Evropski uniji.
English: Further information on Riarify can be found on the Agency's website: https://www.ema.europa.eu/en/medicines/human/EPAR/riarify-previously-chf-5993-chiesifarmaceutici-spa.
Slovenian: Nadaljnje informacije o zdravilu Riarify so na voljo na spletni strani agencije: https://www.ema.europa.eu/en/medicines/human/EPAR/riarify-previously-chf-5993-chiesifarmaceutici-spa.
English: The European Medicines Agency therefore decided that Riarify's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Riarify večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: What measures are being taken to ensure the safe and effective use of Riarify?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Riarify?
English: As for all medicines, data on the use of Riarify is continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Riarify stalno spremljajo.
English: Other information about Riarify
Slovenian: Druge informacije o zdravilu Riarify
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Riarify have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Riarify upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: For more information about using Riarify, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Riarify glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: Side effects reported with Riarify are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Riarify, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: What benefits of Riarify have been shown in studies?
Slovenian: Kakšne koristi zdravila Riarify so se pokazale v študijah?
English: An overview of Riarify and why it is authorised in the EU
Slovenian: Pregled zdravila Riarify in zakaj je odobreno v EU
English: It works in a similar way to naturally occurring corticosteroid hormones, reducing the activity of the immune system.
Slovenian: Deluje podobno kot kortikosteroidni hormoni, ki naravno nastajajo v telesu, in zmanjšuje dejavnost imunskega sistema.
English: The company that makes Trimbow has agreed that its scientific data can be used for Riarify (‘informed consent').
Slovenian: Podjetje, ki proizvaja zdravilo Trimbow, se strinja, da se lahko znanstveni podatki o tem zdravilu uporabijo tudi za zdravilo Riarify („uporaba dokumentacije s soglasjem“).
English: Riarify (beclomethasone / formoterol / glycopyrronium bromide)
Slovenian: Riarify (beklometazon/formoterol/glikopironijev bromid)
English: Patients should be shown how to use the inhaler correctly by a doctor or another healthcare professional, who should also regularly check that the patient's inhalation technique is correct.
Slovenian: Zdravnik ali drug zdravstveni delavec mora bolnikom pokazati, kako pravilno uporabljati inhalator, in tudi redno preverjati, da je bolnikova tehnika inhalacije pravilna.
English: Why is Riarify authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Riarify odobreno v EU?
English: What is Riarify and what is it used for?
Slovenian: Kaj je zdravilo Riarify in za kaj se uporablja?
English: What are the risks associated with Riarify?
Slovenian: Kakšna tveganja so povezana z zdravilom Riarify?
English: It attaches to receptors (targets) known as beta-2 receptors in the muscles of the airways.
Slovenian: Veže se na receptorje (prijemališča), imenovane receptorji beta-2, ki so v mišicah dihalnih poti.
English: Beta-2 agonists and muscarinic receptor antagonists help to widen the airways; corticosteroids reduce inflammation in the airways and lungs.
Slovenian: Agonisti adrenergičnih receptorjev beta-2 in antagonisti muskarinskih receptorjev pomagajo razširiti dihalne poti, kortikosteroidi pa zmanjšujejo vnetje v dihalnih poteh in pljučih.
English: Riarify is available as a liquid in a portable inhaler device.
Slovenian: Zdravilo Riarify je na voljo v obliki tekočine v prenosnem inhalatorju.
English: In the first study lasting a year, after 26 weeks of treatment Riarify improved patients' FEV1 (the maximum volume of air a person can breathe out in one second) by 82 ml before a dose and 261 ml after a dose.
Slovenian: V prvi študiji, ki je trajala eno leto, je zdravilo Riarify po 26 tednih izboljšalo bolnikov FEV1 (največji volumen zraka, ki ga oseba lahko izdihne v eni sekundi) za 82 ml pred prejetim odmerkom in 261 ml po prejetem odmerku.
English: Riarify is a medicine used in adults to relieve the symptoms of moderate to severe chronic obstructive pulmonary disease (COPD).
Slovenian: Riarify je zdravilo, ki se uporablja za lajšanje simptomov zmerne do hude oblike kronične obstruktivne pljučne bolezni (KOPB) pri odraslih.
English: Side effects with Riarify include oral candidiasis (a fungal infection of the mouth caused by a yeast called Candida), muscle spasms and dry mouth.
Slovenian: Neželeni učinki zdravila Riarify vključujejo oralno kandidiazo (glivično okužbo ust, ki jo povzroča kvasovka Candida), mišične krče in suha usta.
English: No major safety concerns have been reported with Riarify, with side effects being manageable and similar to other COPD medicines.
Slovenian: Glede zdravila Riarify niso poročali o večjih varnostnih pomislekih, saj so neželeni učinki obvladljivi in podobni kot pri drugih zdravilih za zdravljenje KOPB.
English: It opens the airways by blocking muscarinic receptors in muscle cells in the lungs.
Slovenian: Odpira dihalne poti, tako da zavira muskarinske receptorje v mišičnih celicah v pljučih.
English: Riarify is used for maintenance (continuing) treatment in patients whose disease is not adequately controlled despite treatment with a combination of two COPD medicines consisting of a long-acting beta-2 agonist plus either an inhaled corticosteroid or a long-acting muscarinic receptor antagonist.
Slovenian: Zdravilo Riarify se uporablja za vzdrževalno (redno) zdravljenje pri bolnikih, pri katerih bolezen ni ustrezno nadzorovana kljub zdravljenju s kombinacijo dveh zdravil za zdravljenje KOPB, sestavljenih iz dolgodelujočega agonista adrenergičnih receptorjev beta-2 in inhalacijskega kortikosteroida ali dolgodelujočega antagonista muskarinskih receptorjev.
English: Beclometasone belongs to anti-inflammatory medicines known as corticosteroids.
Slovenian: Beklometazon spada med protivnetna zdravila, ki se imenujejo kortikosteroidi.
English: Glycopyrronium bromide is a long-acting muscarinic receptor antagonist.
Slovenian: Glikopironijev bromid je dolgodelujoči antagonist muskarinskih receptorjev.
English: For the full list of side effects and restrictions with Riarify, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Riarify glejte navodilo za uporabo.
English: Riarify is effective at reducing the frequency of exacerbations and improving lung function of patients with COPD.
Slovenian: Zdravilo Riarify je učinkovito pri zmanjševanju pogostnosti izbruhov in izboljševanju delovanja pljuč pri bolnikih s KOPB.
English: In the second study lasting a year, patients treated with Riarify had 20% fewer exacerbations (flareups of symptoms) per year than patients treated with tiotropium (a long-acting muscarinic receptor antagonist).
Slovenian: V drugi študiji, ki je trajala eno leto, so imeli bolniki, zdravljeni z zdravilom Riarify, 20 % manj izbruhov bolezni (poslabšanj simptomov) na leto kot bolniki, zdravljeni s tiotropijem (dolgodelujočim antagonistom muskarinskih receptorjev).
English: In the third study lasting a year, patients treated with Riarify had 15% fewer exacerbations a year than patients treated with a combination of indacaterol (a long-acting beta-2 agonist) and glycopyrronium bromide.
Slovenian: V tretji študiji, ki je trajala eno leto, so imeli bolniki, zdravljeni z zdravilom Riarify, 15 % manj izbruhov bolezni na leto kot bolniki, zdravljeni s kombinacijo indakaterola (dolgodelujočega agonista adrenergičnih receptorjev beta-2) in glikopironija.
English: This leads to a reduction in the release of substances involved in the inflammation process, such as histamine, thereby helping to keep the airways clear and allowing the patient to breathe more easily.
Slovenian: S tem se zmanjša sproščanje snovi, ki sodelujejo v procesu vnetja, na primer histamina, kar pripomore k ohranjanju prehodnosti dihalnih poti in bolniku olajša dihanje.
English: How is Riarify used?
Slovenian: Kako se zdravilo Riarify uporablja?
English: In this study, Riarify was as effective as tiotropium plus a combination of beclometasone and formoterol at reducing the number of exacerbations.
Slovenian: V tej študiji je bilo zdravilo Riarify pri zmanjševanju števila izbruhov enako učinkovito kot tiotropij in kombinacija beklometazona in formoterola.
English: Riarify contains the active substances beclometasone, formoterol and glycopyrronium bromide.
Slovenian: Zdravilo Riarify vsebuje učinkovine beklometazon, formoterol in glikopironijev bromid.
English: Because these receptors help control the contraction of the airway muscles, blocking them causes the muscles to relax, helping to keep the airways open and allowing the patient to breathe more easily.
Slovenian: Ker ti receptorji pomagajo pri nadzoru krčenja mišic dihalnih poti, se mišice z zaviranjem receptorjev sprostijo, kar pomaga ohranjati dihalne poti prehodne in bolniku omogoča lažje dihanje.
English: The three active substances in Riarify work in different ways to reduce inflammation and keep the airways open, allowing the patient to breathe more easily.
Slovenian: Tri učinkovine v zdravilu Riarify na različne načine zmanjšujejo vnetje in ohranjajo prehodnost dihalnih poti, kar bolniku omogoča lažje dihanje.
English: By attaching to these receptors, it causes the muscles to relax, which keeps the airways open and helps with the patient's breathing.
Slovenian: Z vezavo na te receptorje sprošča mišice, kar ohranja dihalne poti prehodne in bolniku olajša dihanje.
English: Riarify has been shown to be effective at relieving symptoms of COPD in three main studies involving over 5,500 patients whose symptoms were not controlled well enough either by combinations of two other COPD medicines or by a muscarinic receptor antagonist alone.
Slovenian: V treh glavnih študijah, ki so vključevale več kot 5 500 bolnikov, pri katerih simptomi s kombinacijo dveh drugih zdravil za zdravljenje KOPB ali samostojnim antagonistom muskarinskih receptorjev niso bili ustrezno nadzorovani, so dokazali, da je zdravilo Riarify učinkovito pri lajšanju simptomov KOPB.
English: By comparison, the FEV1 increased by 1 and 145 ml before and after dosing in patients treated with a medicine containing only 2 of the active substances found in Riarify (beclometasone plus formoterol).
Slovenian: Za primerjavo se je pri bolnikih, zdravljenih z zdravilom, ki vsebuje le dve od učinkovin, ki jih vsebuje zdravilo Riarify (beklometazon in formoterol), FEV1 izboljšal za 1 ml pred prejetim odmerkom in 145 ml po prejetem odmerku.
English: This overview was last updated in September 2019.
Slovenian: Ta povzetek je bil nazadnje posodobljen septembra 2019.
English: These usually disappear without any treatment.
Slovenian: Vse te spremembe običajno izginejo brez zdravljenja.
English: Treated cats should not be permitted to sleep with their owners, especially children, on the day of treatment.
Slovenian: Zdravljene mačke na dan zdravljenja ne smejo spati pri svojih lastnikih, zlasti ne pri otrocih.
English: Further information on Vectra Felis can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/vectra-felis.
Slovenian: Nadaljnje informacije o zdravilu Vectra Felis so na voljo na spletni strani agencije: ema.europa.eu/medicines/veterinary/EPAR/vectra-felis.
English: Contact with the skin, eyes or mouth should be avoided.
Slovenian: Izogibati se je treba stiku s kožo, očmi ali usti.
English: The need to re-treat cats and the time interval between treatments requires veterinary assessment.
Slovenian: Potrebo po ponovnem zdravljenju mačk in časovnem intervalu med zdravljenjem mora oceniti veterinar.
English: Vectra Felis received a marketing authorisation valid throughout the EU on 6 June 2014.
Slovenian: Zdravilo Vectra Felis je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 6. junija 2014.
English: People with known hypersensitivity (allergy) to any of the ingredients should avoid contact with the product.
Slovenian: Osebe z znano preobčutljivostjo za (alergijo na) katero koli sestavino naj se izogibajo stiku z zdravilom.
English: Used applicators should be disposed of immediately and not left within the sight or reach of children.
Slovenian: Uporabljene aplikatorje je treba takoj zavreči in jih ne puščati na mestu, ki je vidno ali dosegljivo otrokom.
English: This means that it kills parasites that occur on the skin or in the fur of animals, such as fleas that feed on the animal's skin.
Slovenian: To pomeni, da uniči parazite, ki živijo na koži ali v dlaki živali, kot so bolhe, ki se hranijo s kožo živali.
English: The European Medicines Agency decided that Vectra Felis' benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila Vectra Felis večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: Vectra Felis must not be used in cats or kittens weighing less than 0.6 kg.
Slovenian: Zdravilo Vectra Felis se ne sme uporabljati pri mačkah ali muckah, ki tehtajo manj kot 0,6 kg.
English: Hands should be thoroughly washed immediately after use.
Slovenian: Takoj po uporabi zdravila si je treba temeljito umiti roke.
English: The effectiveness of Vectra Felis against fleas was investigated in a large number of laboratory studies and in one field study.
Slovenian: Učinkovitost zdravila Vectra Felis proti bolham so raziskali v številnih laboratorijskih študijah in eni terenski študiji.
English: Vectra Felis (dinotefuran / pyriproxyfen)
Slovenian: Vectra Felis (dinotefuran/piriproksifen)
English: Dinotefuran is an insecticide which kills insects by acting on receptors (targets) in their nervous system called nicotinic acetylcholine receptors.
Slovenian: Dinotefuran je insekticid, ki uničuje žuželke z delovanjem na receptorje (prijemališča) v njihovem živčnem sistemu, ki se imenujejo nikotinski acetilholinski receptorji.
English: It also prevents fleas from hatching and developing in the cat's environment.
Slovenian: Poleg tega preprečuje, da bi se bolhe izvalile in razvile v okolju mačke.
English: Other information about Vectra Felis
Slovenian: Druge informacije o zdravilu Vectra Felis
English: Vectra Felis (dinotefuran / pyriproxyfen) EMA/206131/2014
Slovenian: Vectra Felis (dinotefuran/piriproksifen) EMA/206131/2014
English: The field study involved 129 cats with flea infestations that were treated once a month for three consecutive months either with Vectra Felis or with another spot-on product containing two different substances, fipronil and (S)-methoprene, that control fleas.
Slovenian: V terensko študijo je bilo vključenih 129 mačk z bolhami, ki so jih tri zaporedne mesece enkrat na mesec zdravili bodisi z zdravilom Vectra Felis bodisi z drugim zdravilom za kožni nanos, ki vsebuje dve različni zdravilni učinkovini, fipronil in (S)-metopren, ki se uporabljata za nadzor bolhavosti.
English: People must not handle treated cats for at least eight hours after application of the veterinary medicine.
Slovenian: Ljudje se morajo stiku z zdravljeno živaljo izogibati vsaj osem ur po nanosu zdravila za uporabo v veterinarski medicini.
English: Vectra Felis was as effective as the comparator product and reduced flea counts by 91% over the 84 day study period.
Slovenian: Zdravilo Vectra Felis je bilo enako učinkovito kot primerjalno zdravilo in je v 84 dneh trajanja študije zmanjšalo število bolh za 91 %.
English: Why is Vectra Felis authorised in the EU?
Slovenian: Zakaj je zdravilo Vectra Felis odobreno v EU?
English: Vectra Felis acts as an ectoparasiticide.
Slovenian: Zdravilo Vectra Felis deluje kot ektoparaziticid.
English: An overview of Vectra Felis and why it is authorised in the EU
Slovenian: Pregled zdravila Vectra Felis in zakaj je odobreno v EU
English: In case of accidental spillage onto skin, the area should be washed off immediately with soap and water.
Slovenian: V primeru nenamernega razlitja po koži je treba površino nemudoma sprati z milom in vodo.
English: Vectra Felis is a veterinary medicine used to treat and prevent flea infestations in cats.
Slovenian: Vectra Felis je zdravilo za uporabo v veterinarski medicini za zdravljenje in preprečevanje infestacij z bolhami pri mačkah.
English: The most common side effects with Vectra Felis (which may affect up to 1 in 1000 cats) are a slight scaling of the skin, temporary redness and itching or temporary hair loss at the application site.
Slovenian: Najpogostejši neželeni učinki zdravila Vectra Felis (ki lahko prizadenejo največ eno mačko od 1 000) so rahlo luščenje kože, prehodna rdečina in srbenje ali prehodna izguba dlake na mestu nanosa.
English: If accidental exposure to the eyes occurs, the eyes should be rinsed with water with the eyelids open and for a sufficient length of time.
Slovenian: Če pride do nenamernega stika z očmi, jih je treba dovolj dolgo spirati z vodo in pri tem držati veke odprte.
English: What benefits of Vectra Felis have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Vectra Felis izkazalo v študijah?
English: If skin or eye irritation persists, or if the veterinary medicine is accidentally swallowed, immediate medical advice should be sought and the package leaflet or label shown to the doctor.
Slovenian: Če je draženje kože ali oči prisotno dalj časa ali če je prišlo do nenamernega zaužitja zdravila, se je treba takoj posvetovati z zdravnikom in mu pokazati navodilo za uporabo ali ovojnino.
English: What are the risks associated with Vectra Felis?
Slovenian: Kakšna tveganja so povezana z zdravilom Vectra Felis?
English: For a full list of all side-effects reported with Vectra Felis, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Vectra Felis, glejte navodilo za uporabo.
English: What is Vectra Felis and what is it used for?
Slovenian: Kaj je zdravilo Vectra Felis in za kaj se uporablja?
English: Pyriproxyfen is an insect growth regulator which stops the flea life cycle by causing production of infertile eggs as well as by blocking the development of immature flea stages into adults.
Slovenian: Piriproksifen je regulator rasti žuželk, ki prekine življenjski cikel bolh, tako da povzroči nastajanje neplodnih jajčec in zavira preobrazbo nezrelih bolh v odrasle bolhe.